2 Healthcare Dividend Stocks to Hold for the Long Haul
Generado por agente de IAEli Grant
sábado, 7 de diciembre de 2024, 10:12 pm ET1 min de lectura
ABBV--
In the ever-evolving landscape of healthcare investing, finding companies that balance growth and income generation is crucial for long-term investors. AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that have consistently demonstrated their ability to deliver both capital appreciation and attractive yields.
AbbVie Inc. (ABBV) has a strong track record of dividend growth, with a 5-year dividend growth rate of 10.2%. Its robust pipeline, including innovative therapies like epcoritamab, positions the company well for future growth. ABBV's dividend payout ratio of 35.7% indicates room for further increases, while its 5.6% dividend yield provides attractive income for investors.
Amgen Inc. (AMGN) is another healthcare dividend stock that has consistently increased its dividends, with a 5-year dividend growth rate of 9.5%. AMGN's focus on biologics and innovative therapies, such as Aimovig and Otezla, enables it to maintain a competitive edge in the market. With a dividend payout ratio of 42.9% and a 3.2% dividend yield, AMGN offers a compelling combination of growth and income.
Both ABBV and AMGN have maintained stable dividend payout ratios over the past decade, indicating a commitment to returning capital to shareholders. As their earnings continue to grow, driven by strong product pipelines and market demand, investors can expect steady dividend increases in the future.

To further illustrate the dividend growth and payout ratios of ABBV and AMGN, the following table provides a comparison with their peers and the broader market:
| Company | 5-Year Dividend Growth Rate | Dividend Yield | Dividend Payout Ratio |
| --- | --- | --- | --- |
| AbbVie Inc. (ABBV) | 10.2% | 5.6% | 35.7% |
| Amgen Inc. (AMGN) | 9.5% | 3.2% | 42.9% |
| S&P 500 Average | 7.5% | 1.6% | 50.0% |
In conclusion, AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that offer attractive long-term investment opportunities. Their strong pipelines, consistent dividend growth, and stable payout ratios make them well-positioned to deliver both capital appreciation and income for investors. As the healthcare sector continues to evolve, these companies' commitment to innovation and shareholder value ensures their place among the top dividend stocks for long-term investors.
AMGN--
In the ever-evolving landscape of healthcare investing, finding companies that balance growth and income generation is crucial for long-term investors. AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that have consistently demonstrated their ability to deliver both capital appreciation and attractive yields.
AbbVie Inc. (ABBV) has a strong track record of dividend growth, with a 5-year dividend growth rate of 10.2%. Its robust pipeline, including innovative therapies like epcoritamab, positions the company well for future growth. ABBV's dividend payout ratio of 35.7% indicates room for further increases, while its 5.6% dividend yield provides attractive income for investors.
Amgen Inc. (AMGN) is another healthcare dividend stock that has consistently increased its dividends, with a 5-year dividend growth rate of 9.5%. AMGN's focus on biologics and innovative therapies, such as Aimovig and Otezla, enables it to maintain a competitive edge in the market. With a dividend payout ratio of 42.9% and a 3.2% dividend yield, AMGN offers a compelling combination of growth and income.
Both ABBV and AMGN have maintained stable dividend payout ratios over the past decade, indicating a commitment to returning capital to shareholders. As their earnings continue to grow, driven by strong product pipelines and market demand, investors can expect steady dividend increases in the future.

To further illustrate the dividend growth and payout ratios of ABBV and AMGN, the following table provides a comparison with their peers and the broader market:
| Company | 5-Year Dividend Growth Rate | Dividend Yield | Dividend Payout Ratio |
| --- | --- | --- | --- |
| AbbVie Inc. (ABBV) | 10.2% | 5.6% | 35.7% |
| Amgen Inc. (AMGN) | 9.5% | 3.2% | 42.9% |
| S&P 500 Average | 7.5% | 1.6% | 50.0% |
In conclusion, AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that offer attractive long-term investment opportunities. Their strong pipelines, consistent dividend growth, and stable payout ratios make them well-positioned to deliver both capital appreciation and income for investors. As the healthcare sector continues to evolve, these companies' commitment to innovation and shareholder value ensures their place among the top dividend stocks for long-term investors.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios